Ilanit Allen | Investor Relations |
Scott Tarriff | Chief Executive Officer |
Pete Meyers | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
Randall Stanicky | RBC Capital Markets |
David Amsellem | Piper Jaffray |
Stephen Ragard | Mizuho |
Good day, and welcome to today’s program. My name is Erica, and I’ll be your conference operator. At this time, I’d like to welcome everyone to Eagle Pharmaceuticals’ Second Quarter 2018 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer period.